No price history available.
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 292 | 276 | -5 | 286 | 350 | 87 | N/A | N/A |
| Operating profit | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | €m | 206 | 174 | -59 | 217 | 219 | 173 | N/A | N/A |
| EPS reported | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | €m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | € | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Gimv N.V. operates as an investment company, specializing in both direct private equity and venture capital placements, alongside committing capital to other funds. Its direct investment approach spans a comprehensive range of stages and financing structures. This includes supporting startups from seed, early, and mid-stages through to late venture and emerging growth, as well as engaging in pre-revenue, middle-market, and mature company investments. The firm facilitates buyouts, growth capital, public-to-private transactions, recapitalizations, and provides debt, shareholder loans, replacement capital, and bridge financing to small and medium-sized enterprises (SMEs). Through its fund of funds strategy, Gimv allocates capital to other venture capital and private equity vehicles. The firm targets high-potential growth companies capable of accelerating their expansion, often through a combination of organic development and strategic acquisitions. Gimv's investment focus is broad, encompassing sectors such as consumer goods and connected consumer technologies, R&D-intensive businesses positively impacting human health and the environment, automation, health and care, demographic shifts, financial services (including consumer digital lending), telecommunication services, marketing services, interactive home entertainment, smart industries, and sustainable urban development. Within its health and care platform, Gimv prioritizes companies poised for growth via internal expansion or a "buy-and-build" acquisition strategy. More specifically, the consumer vertical covers areas like consumer goods, various food categories (including healthy, prepared, and preserved), personal luxury items, home decor and building, household appliances, specialized housewares, travel and leisure, education, and sectors driven by digitalization and the digital economy. In the health and care arena, it targets life sciences, medical technology (medtech), healthcare services, veterinary pharmaceuticals, generic drugs, vaccines, diagnostic testing, and a range of medical devices and consumables. Its Smart Industries platform includes aerospace, energy transition, business-to-business (B2B) services, advanced engineering, and software solutions. The Sustainable Cities platform delves into infrastructure deployment, energy systems, recycling and recovery, transport and logistics, water purification, e-commerce, alternative energy sources, and energy-efficient infrastructure, as well as consumer-related services within these themes. Additionally, Gimv considers investments in building materials (including chemicals, fertilizers, and agricultural chemicals), mobility solutions, operational services, agricultural services, electronics, and heavy electrical equipment. Geographically, Gimv concentrates its efforts primarily within the DACH region (Austria, Germany, Switzerland), the Benelux countries, France, and the United Kingdom. It also has a presence in Italy, Luxembourg, the Netherlands, Russia, Kazakhstan, the Czech Republic, and Slovakia. Its investments target small and medium-sized enterprises (SMEs), predominantly those headquartered in the Benelux, France, and Germany. Investment amounts typically range from €5 million ($5.67 million) to €150 million ($170.22 million), primarily within its consumer, healthcare, smart industries, and sustainable cities platforms. Gimv is flexible regarding ownership, taking either majority or minority stakes in its portfolio companies. Established on February 25, 1980, Gimv N.V. is headquartered in Antwerp, Belgium, and maintains additional offices across Europe, including Paris (France), The Hague (Netherlands), Frankfurt am Main and Munich (Germany), London (United Kingdom), Prague (Czech Republic), and Warsaw (Poland).
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Gimv N.V. operates as an investment company, specializing in both direct private equity and venture capital placements, alongside committing capital to other funds. Its direct investment approach spans a comprehensive range of stages and financing structures. This includes supporting startups from seed, early, and mid-stages through to late venture and emerging growth, as well as engaging in pre-revenue, middle-market, and mature company investments. The firm facilitates buyouts, growth capital, public-to-private transactions, recapitalizations, and provides debt, shareholder loans, replacement capital, and bridge financing to small and medium-sized enterprises (SMEs). Through its fund of funds strategy, Gimv allocates capital to other venture capital and private equity vehicles. The firm targets high-potential growth companies capable of accelerating their expansion, often through a combination of organic development and strategic acquisitions. Gimv's investment focus is broad, encompassing sectors such as consumer goods and connected consumer technologies, R&D-intensive businesses positively impacting human health and the environment, automation, health and care, demographic shifts, financial services (including consumer digital lending), telecommunication services, marketing services, interactive home entertainment, smart industries, and sustainable urban development. Within its health and care platform, Gimv prioritizes companies poised for growth via internal expansion or a "buy-and-build" acquisition strategy. More specifically, the consumer vertical covers areas like consumer goods, various food categories (including healthy, prepared, and preserved), personal luxury items, home decor and building, household appliances, specialized housewares, travel and leisure, education, and sectors driven by digitalization and the digital economy. In the health and care arena, it targets life sciences, medical technology (medtech), healthcare services, veterinary pharmaceuticals, generic drugs, vaccines, diagnostic testing, and a range of medical devices and consumables. Its Smart Industries platform includes aerospace, energy transition, business-to-business (B2B) services, advanced engineering, and software solutions. The Sustainable Cities platform delves into infrastructure deployment, energy systems, recycling and recovery, transport and logistics, water purification, e-commerce, alternative energy sources, and energy-efficient infrastructure, as well as consumer-related services within these themes. Additionally, Gimv considers investments in building materials (including chemicals, fertilizers, and agricultural chemicals), mobility solutions, operational services, agricultural services, electronics, and heavy electrical equipment. Geographically, Gimv concentrates its efforts primarily within the DACH region (Austria, Germany, Switzerland), the Benelux countries, France, and the United Kingdom. It also has a presence in Italy, Luxembourg, the Netherlands, Russia, Kazakhstan, the Czech Republic, and Slovakia. Its investments target small and medium-sized enterprises (SMEs), predominantly those headquartered in the Benelux, France, and Germany. Investment amounts typically range from €5 million ($5.67 million) to €150 million ($170.22 million), primarily within its consumer, healthcare, smart industries, and sustainable cities platforms. Gimv is flexible regarding ownership, taking either majority or minority stakes in its portfolio companies. Established on February 25, 1980, Gimv N.V. is headquartered in Antwerp, Belgium, and maintains additional offices across Europe, including Paris (France), The Hague (Netherlands), Frankfurt am Main and Munich (Germany), London (United Kingdom), Prague (Czech Republic), and Warsaw (Poland).
